Accelerating Stroke Recovery: Body Structures and Functions, Activities, Participation, and Quality of Life Outcomes From a Large Rehabilitation Trial.
Rebecca Lewthwaite, Carolee J Winstein, Christianne J Lane and 5 others
PMID 29554849WHAT IT FOUND
The trial's main motor outcome showed no group difference at 1 year.
In secondary outcomes, ASAP produced faster early gains in confidence, function, participation and quality of life; usual care caught up by 12 months.
Key findings
01The primary outcome, Wolf Motor Function Test motor performance at 1 year, improved substantially but did not differ among the three groups.
02During treatment, ASAP showed faster gains on many secondary outcomes. During follow-up, usual-care groups improved more and caught up by end of study.
03At end of study, ASAP participants reported greater strength than the usual-care groups.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This paper reports secondary outcomes; the trial's primary motor outcome did not differ between groups at 1 year. Participants had mild to moderate arm and hand impairment and mild stroke, so the results may not apply to people with severe upper-limb impairment or other stroke syndromes. The therapy was started between 14 and 106 days after stroke, so it says little about chronic stroke or very early inpatient care. ASAP was a multi-component programme, including therapist-delivered skill practice, participant-selected tasks, confidence building and action planning, so the paper cannot show which part produced early gains. Many secondary outcomes were tested, so early patient-reported differences should not be treated as proof of long-term superiority. Some patient-experience measures were collected by non-blinded staff, and several outcomes were self-reported. The supplied text does not report how many participants dropped out or were analysed at each time point. Usual care content was determined by treating clinicians, so comparison groups were not a single standardized therapy. Group differences largely disappeared by end of study, with exceptions in patient-reported strength and quality-of-life items.
Declared interests
The supplied metadata lists NIH and non-U.S. government research support, and the authors declared no conflict of interest. The supplied text does not report a sponsor designing the study or writing the manuscript.
The easy way to misread this
Do not read the faster early patient-reported gains as proof that ASAP gives better long-term arm recovery. The main motor outcome showed no difference at 1 year, and many secondary differences narrowed as usual care groups caught up. ASAP was also a multi-component programme, so the paper cannot show which part produced the early differences.